In 2,908 patients with high-risk breast cancer needing locoregional radiotherapy, 40Gy/15fx was non-inferior to 50Gy/25fx for 3-year arm lymphoedema (8.0% vs 9.4%; OR 0.84), with no differences in recurrence, breast cancer or all-cause mortality.
RCTn = 2,908
Offersen et al. Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1